Introduction

Defymed® is a company that aims to develop and market implantable bio-artificial medical devices for diverse therapeutic applications.

Defymed® is a company that develops implantable bio-artificial medical devices for diverse therapeutic applications, with a first focus on type 1 diabetes. The blockbuster product is a bio-artificial pancreas, named MAILPAN® (MAcro-encapsulation of PANcreatic Islets). Defymed® is a spin-off of the CeeD (Centre europeen d’etude du Diabete) which has been working on an innovative concept of a bio-artificial pancreas since 1996. This work of conception of a macro-encapsulation device of insulin-secretory cells was carried out in collaboration with STATICE and the CTTM (Centre de Transfert de Technologies du Mans) in the frame of two European programs: 4th PCRD (1996-2000) and 6th PCRD (2004-2007).

About us

Defymed is a spin -off of the “Centre Europeen d’etude du Diabete” (CeeD) which has been working on the conception of a bio-artificial pancreas since 1996. This work has been carried out in ...

learn more about us

Problematic

Diabetes mellitus is a chronic metabolic disorder that is caused by a failure of the body to produce insulin and/or an inability of the body to respond adequately to circulating insulin. The principal functions of insulin, secreted...

learn more about the problematic